Compare EDUC & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EDUC | EVGN |
|---|---|---|
| Founded | 1965 | 1999 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Agricultural Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8M | 10.9M |
| IPO Year | N/A | N/A |
| Metric | EDUC | EVGN |
|---|---|---|
| Price | $1.31 | $1.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 24.4K | ★ 46.7K |
| Earning Date | 01-12-2026 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $29,415,900.00 | $8,016,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.35 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.19 |
| 52 Week Low | $0.92 | $0.95 |
| 52 Week High | $1.93 | $2.42 |
| Indicator | EDUC | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 49.94 | 36.27 |
| Support Level | $1.23 | $1.07 |
| Resistance Level | $1.34 | $1.12 |
| Average True Range (ATR) | 0.08 | 0.05 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 73.33 | 17.36 |
Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.